Technical report on 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe). Annex 2 to the “Risk Assessment Report of a new psychoactive substance: 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe)”.

Elliott, S and Brandt, SD (2014) Technical report on 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe). Annex 2 to the “Risk Assessment Report of a new psychoactive substance: 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe)”. Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Preview

Text EMCDDA_25I-NBOMe_TR.pdf - Published Version Download (403kB) | Preview

Abstract

This report forms the basis for a risk assessment, which is convened by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) under auspices of its Scientific Committee and other externally invited experts. Furthermore, the Commission, Europol and the EMA are invited to participate in the risk assessment meetings. The risk assessment takes into account all factors that, according to the 1961 United Nations Single Convention on Narcotic Drugs or the 1971 United Nations Convention on Psychotropic Substances, would warrant the placing of a substance under international control (see http://www.emcdda.europa.eu/html.cfm/index16776EN.html).

Item Type:	Monograph (Technical Report)
Subjects:	Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology
Divisions:	Pharmacy and Biomolecular Sciences
Publisher:	European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Date of acceptance:	1 January 2014
Date of first compliant Open Access:	23 October 2017
Date Deposited:	23 Oct 2017 10:31
Last Modified:	24 Jan 2022 11:15
URI:	https://ljmu-9.eprints-hosting.org/id/eprint/7403

View Item